News and Comments

ARCA BIOPHARMA: A GENETICALLY TARGETED DRUG FOR ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS

  Thursday, January 09, 2014

A Colorado-based biopharmaceutical company, ARCA Biopharma (ABIO) has a genetically-targeted drug, GencaroTM (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach for the treatment of AF in HF, treating only individuals with certain genetic characteristics. This approach enables the selection of individuals who would most probably respond to the drug through excluding the expected non-responders, thus reducing statistically failed trial outcome, in addition to decreasing clinical trial and healthcare costs.    More...


Recent Postings


Archive


Tags

Ionis (IONS) Biogen Idec (BIIB) Prosensa (RNA) Vertex (VRTX) Aimmune Therapeutics (AIMT) NANTKWEST (NK) Auspex (ASPX) Revlimid (lenolidamide) Alder Biopharmaceuticals (ALDR) Vitae Pharmaceuticals (VTAE) HALOZYME (HALO) Intercept (ICPT) Endometrial Cancer Biocryst (BCRX) ABBVIE (ABBV) Exelixis (EXEL) Alnylam (ALNY) SERES THERAPEUTICS (MCRB) Zerenex Human Longevity (HLI) Herceptin Roche (RHHBY) Abbott Laboratories (ABT) Xoma (XOMA) Ariad (ARIA) VANDA (VNDA) Anadys (ANDS) Multiple Myeloma Merck (MRK) CompuGen (CGEN) REGULUS (RGLS) KERYX (KERX) Ziofpharm (ZIOP) Ridaforolimus GlaxoSmithKline (GSK) Benlysta (belimumab) ZALTRAP™ Sanofi (SNA) Cytokinetics (CYTK) SYNTA (SNTA) SUNESIS PHARMACEUTICALS (SNSS) Inovio (INO) Prolor Biotech (PBTH) Trastuzumab-DM1 Dynavax (DVAX) Micromet (MITI) Amgen (AMGN) AERIE PHARMACEUTICALS Anacor (ANAC) ADVENTRIX (ANX) galapagos (GLPG) Sarepta (SRPT) OSI (OSIP) KITE (KITE) JUNO (JUNO) Gilead (GILD) ImmunoGen (IMGN) Onyx (ONXX) Jazz Pharmaceuticals (JAZZ) Telaprevir Theravance (THRX) Agenus (AGEN Sanofi (SNY) ARCA (ABIO) Tysabri NEKTAR (NKTR)) Mirati Therapeutics (MRTX) Agenus (AGEN) BIOMARIN (BMRN) Pluristem (PSTI) Dendreon (DNDN) Roche (ROCHE) Sequenom (SQNM) Idenix (IDIX) Sanofi-Aventis (SAN) Intermune (ITMN) ISIS (ISIS) Theravance Bio Pharma (TBPH) Galena (GALE) Regeneron (REGN) TOKAI (TKAOI) Incyte (INCY) IDERA (IDRA) C4 Therapeutics GUARDIAN HEALTH Genentech Intrexon (XON) Velcade (bortezomib) Seattle Genetics (SGEN) ACADIA (ACAD) Valeant Pharmaceuticals International (VRX) Illumina (ILMN) Human Genome Sciences (HGSI) Bristol-Myers Squibb (BMY) Rapamune Sangamo (SGMO) Array Pharmaceuticals (ARRY) Elan (ELN)